"Moment-by-moment quantification of the individual-level human phenotype in-situ utilizing data from cellphones and other personal digital devices," according to the definition of digital phenotyping. To put it another way, this technology makes use of sensors to track a person's behavior, location, and speech patterns (e.g., intonation). The measuring focus is not on content (what you write), but on how you type, when assessing human-computer interaction (for example, the use of a smartphone). Machine learning is used to aggregate and evaluate these interactions—the patterns and timings of user activity on touch-screen devices. Digital "biomarkers" relate to the outcomes of these interactions. As a clinical tool, digital phenotyping is currently being developed. Digital technologies and techniques have a lot of potential. Indeed, the COVID-19 pandemic has demonstrated the value of telehealth platforms and mental health applications (apps) during a period of quarantine and social isolation.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States